Details of the Drug
General Information of Drug (ID: DMK9BRV)
| Drug Name |
Pidotimod
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
Pgt-1A; 117241-40-4; 3-Pyroglutamylthiazolidine-4-carboxylic acid; 3-(5-oxopyrrolidine-2-carbonyl)thiazolidine-4-carboxylic acid; NSC678119; 3-((5-Oxo-2-pyrrolidinyl)carbonyl)-4-thiazolidinecarboxylic acid; 3-L-pyroglutamyl-L-thiazolidine-4-carboxylic acid; 4-Thiazolidinecarboxylic acid, 3-((5-oxo-2-pyrrolidinyl)carbonyl)-; C9H12N2O4S; 3-(5-oxoprolyl)-1,3-thiazolidine-4-carboxylic acid; ACMC-20emtr; ACMC-209vwo; AC1L3FWE; MLS006011471; SCHEMBL9342892; CTK0H7615; MolPort-004-328-744; 4-Thiazolidinecarboxylicacid, 3-[[(2S)-5-
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Affected Organisms |
Humans and other mammals
|
||||||||||||||||||||||
| ATC Code | |||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||

